Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Daniel Sontupe
Market Access

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy